Entrar/Registro  
INICIO ENGLISH
 
Cirugía y Cirujanos
   
MENÚ

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor

Directorio






>Revistas >Cirugía y Cirujanos >Año 2018, No. 5


Martínez-Ramos D, Simón-Monterde L, Suelves-Piqueres C, Queralt-Martí R, Laguna-Sastre M
Linfoma anaplásico de células grandes asociado a implantes mamarios. Importancia para el cirujano
Cir Cir 2018; 86 (5)

Idioma: Español
Referencias bibliográficas: 33
Paginas: 459-464
Archivo PDF: 159.14 Kb.


Texto completo




RESUMEN

El linfoma anaplásico de células grandes asociado a implantes mamarios (BIA-ALCL, breast implant associated-anaplastic large cell lymphoma) es una enfermedad infrecuente, pero el número de casos ha aumentado en los últimos años. Se puede presentar en la consulta del cirujano como un aumento del volumen mamario por derrame periprotésico o como masa capsular. El tratamiento de elección es la cirugía, con explante de las prótesis y exéresis de la cápsula periprotésica. El pronóstico, si el diagnóstico es precoz y el tratamiento es adecuado, es bueno. El objetivo del presente trabajo fue revisar la literatura científica existente hasta la fecha sobre el BIA-ALCL y poner de manifiesto la importancia que este tipo de neoplasia tiene para el cirujano.


Palabras clave: Linfoma anaplásico, Células grandes, Implantes mamarios.


REFERENCIAS

  1. Rocco N, Rispoli C, Moja L, Amato B, Iannone L, Testa S, et al. Different types of implants for reconstructive breast surgery. Cochrane Database Syst Rev. 2016;(5):CD010895.

  2. Johnson L, O’Donoghue JM, McLean N, Turton P, Khan AA, Turner SD. Breast implant associated anaplastic large cell lymphoma: the UK experience. Recommendations on its management and implications for informed consent. Eur J Surg Oncol. 2017;43:1393-401.

  3. Stein H, Mason DY, Gerdes J, O’Connor N, Wainscoat J, Pallesen G, et al. The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985;66:848-58.

  4. Sathyanarayanan V, Lokesh KN, Lakshmaiah KC, Govind Babu K, Lokanatha D, Suresh Babu MC, et al. Anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma (ALCL) of breast in a patient without a breast implant. Ann Saudi Med. 2014;34:551-4.

  5. Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997;100:554-5.

  6. Nogueira Batista B, Garicochea B, Nunes Aguilar VL, Carvalho FM, Millan LS, Pires Fraga MF. Report of a case of anaplastic large cell lymphoma associated with a breast implant in a Brazilian patient. Rev Bras Cir Plast. 2017;32:445-9.

  7. Letter H, Rop B, Edison MN, Turner P. Breast implant-associated anaplastic large cell lymphoma: a case report and literature review. Cureus. 2016;8:e546.

  8. Hwang MJ, Brown H, Murrin R, Momtahan N, Sterne GD. Breast implant- associated anaplastic large cell lymphoma: a case report and literature review. Aesthetic Plast Surg. 2015;39:391-5.

  9. Evren S, Khoury T, Neppalli V, Cappuccino H, Hernández-Ilizaliturri FJ, Kumar P. Breast implant-associated anaplastic large cell lymphoma (ALCL): a case report. Am J Case Rep. 2017;18:605-10.

  10. Zimmerman A, Locke FL, Emole J, Rosa M, Horna P, Hoover S, et al. Recurrent systemic anaplastic lymphoma kinase-negative anaplastic large cell lymphoma presenting as a breast implant-associated lesion. Cancer Control. 2015;22:369-73.

  11. Popplewell L, Thomas SH, Huang Q, Chang KL, Forman SJ. Primary anaplastic large-cell lymphoma associated with breast implants. Leuk Lymphoma. 2011;52:1481-7.

  12. Xu J, Wei S. Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity. Arch Pathol Lab Med. 2014;138:842-6.

  13. Center for Devices and Radiological Health U.S. Food and Drug. Anaplastic large cell lymphoma (ALCL) in women with breast implants: preliminary FDA findings and analyses. 2011. (Consultado el 14 de diciembre de 2017.) Disponible en: https://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ ucm239995.htm.

  14. Center for Devices and Radiological Health U.S. Food and Drug. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). 2017. (Consultado el 14 de diciembre de 2017.) Disponible en: https://www. fda gov/medicaldevices/productsandmedicalprocedures/implantsandprosthetics/ breastimplants/ucm239995.htm.

  15. Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S, et al. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol. 2016;34:160-8.

  16. Torres-Rivero C, Ramos-Gallardo G, Nambo-Lucio MJ, Vaquero-Pérez MM. Primer caso en México y América Latina de linfoma anaplásico de células gigantes en paciente con implantes mamarios. Cir Plast. Iberolatinoam. 2016;42:175-80.

  17. O’Neill AC, Zhong T, Hofer SOP. Implications of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) for breast cancer reconstruction: an update for surgical oncologists. Ann Surg Oncol. 2017;24: 3174-9.

  18. Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, et al. U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2017;139:1042-50.

  19. Kaartinen I, Sunela K, Alanko J, Hukkinen K, Karjalainen-Lindsberg ML, Svarvar C. Breast implant-associated anaplastic large cell lymphoma — from diagnosis to treatment. Eur J Surg Oncol. 2017;43:1385-92.

  20. Leberfinger AN, Behar BJ, Williams NC, Rakszawski KL, Potochny JD, Mackay DR, et al. Breast implant-associated anaplastic large cell lymphoma: a systematic review. JAMA Surg. 2017;152:1161-8.

  21. Vase MØ, Friis S, Bautz A, Bendix K, Sørensen HT, d’Amore F. Breast implants and anaplastic large-cell lymphoma: a Danish population-based cohort study. Cancer Epidemiol Biomarkers Prev. 2013;22:2126-9.

  22. George EV, Pharm J, Houston C, Al-Quran S, Brian G, Dong H, et al. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis. Int J Clin Exp Pathol. 2013;6:1631-42.

  23. Hu H, Johani K, Almatroudi A, Vickery K, Van Natta B, Kadin ME, et al. Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg. 2016;137:1659-69.

  24. Fernández-Sobrino I, Cordones-Guerrero JJ, Benítez-Dupin O, Cornejo- Ladrero JI, Lobo-Samper F. Palpable mass as an atypical presentation of breast implants-associated anaplastic large cell lymphoma. Cir Plast Iberolatinoam. 2017;43:129-35.

  25. Clemens MW, Nava MB, Rocco N, Miranda RN. Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules. Gland Surg. 2017;6:169-84.

  26. Alcalá R, Llombart B, Lavernia J, Traves V, Guillén C, Sanmartín O. Skin involvement as the first manifestation of breast implant-associated anaplastic large cell lymphoma. J Cutan Pathol. 2016;43:602-8.

  27. Clemens MW, Horwitz SM. NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2017;37:285-9.

  28. Ramos-Gallardo G, Cuenca-Pardo J, Rodríguez-Olivares E, Iribarren- Moreno R, Contreras-Bulnes L, Vallarta-Rodríguez A, et al. Breast implant and anaplastic large cell lymphoma meta-analysis. J Invest Surg. 2017;30:56-65.

  29. Adrada BE, Miranda RN, Rauch GM, Arribas E, Kanagal-Shamanna R, Clemens MW, et al. Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients. Breast Cancer Res Treat. 2014;147:1-14.

  30. Acevedo-Báñez I, García-Gómez FJ, Jiménez-Granero P, Carrillo- Cruz E, Pérez-López O, Borrego-Dorado I. 18F-FDG-PET/CT in implant- associated anaplastic large cell lymphoma of the breast. Br J Haematol. 2015;169:1.

  31. Laurent C, Delas A, Gaulard P, Haioun C, Moreau A, Xerri L, et al. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol. 2016;27:306‑14.

  32. Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, de Jong D, Fayad LE, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol. 2014;32:114-20.

  33. Clemens MW, Miranda RN, Butler CE. Breast implant informed consent should include the risk of anaplastic large cell lymphoma. Plast Reconstr Surg. 2016;137:1117-22.



>Revistas >Cirugía y Cirujanos >Año2018, No. 5
 

· Indice de Publicaciones 
· ligas de Interes 






       
Derechos Resevados 2019